Crossbow Therapeutics Inc

Crossbow Therapeutics Inc. is a biotechnology company headquartered in Cambridge, Massachusetts. Currently, the company employs 39 individuals. Crossbow Therapeutics specializes in developing innovative immunotherapies known as T-Bolt™ therapies. These therapies utilize T-cell receptor (TCR)-mimetic antibodies, designed to precisely target previously inaccessible cancer cell targets. Their aim is to revolutionize cancer treatment by expanding the scope of antibody therapy to encompass a wider range of cancers. Crossbow Therapeutics distinguishes itself through its efficient and selective approach to cancer targeting. Their T-Bolt™ therapies leverage the power of TCR-mimetic antibodies, enabling them to address the vast universe of cancer proteins. This targeted strategy holds immense promise for improving the lives of cancer patients. For more information about Crossbow Therapeutics Inc. and their groundbreaking therapies, please visit their website at crossbowtx.com.